Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study

Mo, XF; Zhou, MG; Yan, H; Chen, XQ; Wang, YT

Wang, YT (corresponding author), Soochow Univ, Changzhou Key Lab Mol Imaging, Affiliated Hosp 3, Dept Nucl Med, Changzhou 213003, Jiangsu, Peoples R China.

CANCER MEDICINE, 2021; 10 (15): 5338

Abstract

Background Patients with prostate cancer (PC) are at a high risk of developing secondary hematologic malignancies (SHMs) after radiation therapy (RT),......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索